Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$1.53B |
| 2 |
American Express
AXP
|
+$368M |
| 3 |
Capital One
COF
|
+$138M |
| 4 |
DFS
Discover Financial Services
DFS
|
+$98.1M |
| 5 |
Apollo Global Management
APO
|
+$96.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.04B |
| 2 |
Microsoft
MSFT
|
+$804M |
| 3 |
Amazon
AMZN
|
+$353M |
| 4 |
NVIDIA
NVDA
|
+$280M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$271M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.2% |
| 2 | Healthcare | 13.75% |
| 3 | Consumer Discretionary | 12.04% |
| 4 | Industrials | 9.24% |
| 5 | Communication Services | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Carter's
CRI
$1.44B
| $5.98M | ﹤0.01% |
82,400
| – | – |
|
|
NARI
1202
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $5.98M | ﹤0.01% |
102,800
+10,100
| +11% | +$637K |
|
|
ENLC
1203
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $5.97M | ﹤0.01% |
563,623
+1,400
| +0.2% | +$14K |
|
1204
Transmedics
TMDX
$3.11B
| $5.95M | ﹤0.01% |
70,900
+5,400
| +8% | +$413K |
|
1205
Methanex
MEOH
$4.19B
| $5.95M | ﹤0.01% |
143,900
+22,100
| +18% | +$955K |
|
1206
Cactus
WHD
$5.78B
| $5.94M | ﹤0.01% |
140,300
+9,300
| +7% | +$362K |
|
1207
Carpenter Technology
CRS
$26.6B
| $5.93M | ﹤0.01% |
105,600
+1,100
| +1% | +$53.8K |
|
1208
Plexus
PLXS
$7.04B
| $5.92M | ﹤0.01% |
60,300
+600
| +1% | +$55K |
|
1209
Sabra Healthcare REIT
SBRA
$5.15B
| $5.92M | ﹤0.01% |
503,241
+4,700
| +0.9% | +$53.5K |
|
1210
Acadia Pharmaceuticals
ACAD
$4.89B
| $5.92M | ﹤0.01% |
247,304
-14,800
| -6% | -$329K |
|
1211
Rapid7
RPD
$929M
| $5.92M | ﹤0.01% |
130,700
+2,900
| +2% | +$134K |
|
1212
CNO Financial Group
CNO
$5.07B
| $5.92M | ﹤0.01% |
250,000
+3,000
| +1% | +$66.8K |
|
1213
Core & Main
CNM
$8.64B
| $5.9M | ﹤0.01% |
188,400
+39,700
| +27% | +$1.06M |
|
1214
PTC Therapeutics
PTCT
$6.01B
| $5.88M | ﹤0.01% |
144,665
+5,100
| +4% | +$250K |
|
1215
Prothena Corp
PRTA
$466M
| $5.87M | ﹤0.01% |
85,900
+12,800
| +18% | +$826K |
|
1216
OR Royalties Inc
OR
$6.15B
| $5.85M | ﹤0.01% |
380,230
| – | – |
|
1217
Flywire
FLYW
$2.22B
| $5.85M | ﹤0.01% |
188,400
+120,800
| +179% | +$3.62M |
|
1218
ESCO Technologies
ESE
$7.79B
| $5.82M | ﹤0.01% |
56,200
+400
| +0.7% | +$38.4K |
|
1219
COPT Defense Properties
CDP
$4.23B
| $5.82M | ﹤0.01% |
245,000
+2,300
| +0.9% | +$53.6K |
|
1220
Artisan Partners
APAM
$3.03B
| $5.81M | ﹤0.01% |
147,900
+1,300
| +0.9% | +$44.9K |
|
|
FOLD
1221
DELISTED
Amicus Therapeutics
FOLD
| $5.8M | ﹤0.01% |
461,600
+6,800
| +1% | +$80.7K |
|
1222
Werner Enterprises
WERN
$2.31B
| $5.79M | ﹤0.01% |
131,100
+8,300
| +7% | +$373K |
|
1223
RingCentral
RNG
$5.66B
| $5.79M | ﹤0.01% |
176,900
+700
| +0.4% | +$21.5K |
|
|
AYX
1224
DELISTED
Alteryx Inc
AYX
| $5.79M | ﹤0.01% |
127,500
-4,600
| -3% | -$201K |
|
1225
Alight
ALIT
$394M
| $5.77M | ﹤0.01% |
31,235
+3,670
| +13% | +$651K |
|
Similar funds
Swiss National Bank's Q2 2023 Portfolio in Review
As of Q2 2023, Swiss National Bank held 2,706 positions worth $147B, up 0.92% from $146B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Swiss National Bank withdrew a net $9.97B in Q2 2023, closing 106 positions and reducing 972 holdings. Its most notable exit was Shaw Communications Inc., an estimated $57.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Swiss National Bank opened a new position in Berkshire Hathaway Class B worth $1.6B.
- Swiss National Bank's largest Q2 2023 buy was Berkshire Hathaway Class B: 4,684,505 shares worth $1.6B.
- Swiss National Bank added most to Uber in Q2 2023, an estimated $22.7M increase.
- Swiss National Bank's biggest Q2 2023 reduction was Apple, cutting an estimated $1.04B.
- Swiss National Bank fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $57.3M.
- Swiss National Bank's ten largest holdings make up 28% of its $147B portfolio in Q2 2023.
- Swiss National Bank opened 63 new positions and closed 106 in Q2 2023.
- Swiss National Bank's portfolio value rose 0.92% quarter-over-quarter to $147B.
Based on Swiss National Bank's 13F filing for Q2 2023, filed 9 Aug 2023.